Bliss GVS Pharma Limited

Web: blissgvs.com NSE: BLISSGVS BSE: 506197 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

530 7(1%)

Near 52W High of 553

Volume

10L as on 23, Jun

Open

159

High

162

Low

158

524

VWAP

467

52 Week High

553

52 Week Low

118

Viand Research Rating

Quality Score

55/100

Growth Score

52/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

5,608

No. of Shares

10.6

P/E

36.77

P/B

1.64

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

4.46

ROCE

Profit Growth

Listing Date

26-Jul-10

Promoter Holding

35.36%

FII Holding

10.45%

DII Holding

5.04%

Price Chart

Price Performance

1 Week4%

1 Month57%

3 Months142%

6 Months111%

1 Year111%

YTD111%

Moving Average

5 Day SMA477

10 Day SMA458

20 Day SMA440

30 Day SMA390

50 Day SMA340

61 Day SMA320

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	510	480	500	505
Resistance 2	500	478	490	497
Resistance 1	486	475	485	482
Pivot Point	476	473	476	473
Support 1	463	471	467	458
Support 2	452	469	461	450
Support 3	439	467	452	434

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 35.36%	(0.01) 35.36%	(0.01) 35.39%	(0.11) 35.44%	(0.21) 35.29%	(0.31) 35.10%	(-0.11) 34.82%	(-0.11) 34.90%	(0.01) 34.97%	(-0.11) 34.97%	(-0.11) 35.06%	(0.11) 35.12%	(0.61) 35.04%	(-0.11) 34.46%	(0.01) 34.55%	(1.41) 34.51%	(0.01) 33.14%	(0.01) 33.14%	(0.01) 33.19%
FIIs	(-4.11) 10.45%	(1.31) 14.54%	(0.61) 13.27%	(-0.51) 12.65%	(-0.31) 13.18%	(1.41) 13.51%	(-1.11) 12.13%	(-1.51) 13.24%	(-0.61) 14.74%	(-1.01) 15.35%	(-0.21) 16.31%	(-0.11) 16.50%	(0.11) 16.60%	(-0.11) 16.53%	(-0.51) 16.68%	(-0.21) 17.17%	(-2.31) 17.33%	(-1.41) 19.59%	(0.01) 21.01%
DIIs	(-0.71) 5.04%	(-0.21) 5.78%	(-0.61) 5.98%	(0.01) 6.54%	(0.01) 6.55%	(0.01) 6.55%	(0.01) 6.56%	(0.01) 6.58%	(0.01) 6.59%	(0.01) 6.60%	(0.01) 6.61%	(0.01) 6.62%	(0.01) 6.63%	(0.01) 6.63%	(0.01) 6.64%	(0.01) 6.65%	(0.01) 6.66%	(0.01) 6.66%	(0.01) 6.67%
Public	49.15%	44.32%	45.36%	45.37%	44.98%	44.84%	46.49%	45.27%	43.71%	43.08%	42.00%	41.73%	41.73%	42.35%	42.13%	41.67%	42.87%	40.61%	39.13%
No. of Shareholders	44,874	43,380	44,461	46,707	49,517	49,558	52,937	44,737	45,157	40,758	43,234	42,182	43,041	44,983	45,753	46,327	45,866	41,080	42,742

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	257	218	244	207	198	210	218	184	198	201	212	160	185	206	172	189	167	216	196	168
Sales Growth % (YoY)	-	3.7%	12.3%	13%	-0.1%	4.8%	2.7%	15.1%	7.2%	-2.4%	22.9%	-15.4%	10.6%	-4.9%	-12%	12.2%	26.5%	31.8%	29.3%	29.8%
Sales Growth % (QoQ)	17.9%	-10.7%	17.9%	4.5%	-5.7%	-3.7%	18.5%	-7.1%	-1.5%	-5.2%	32.5%	-13.5%	-10.2%	19.8%	-9%	13.2%	-22.7%	10.2%	16.7%	-
Expenses	213	183	201	166	177	181	176	149	170	157	158	135	179	158	148	150	147	182	167	134
Operating Profit	44	35	43	41	21	30	41	34	28	44	54	24	6	48	25	39	20	34	29	35
OPM %	17	16	18	20	11	14	19	19	14	22	26	15	3	23	14	21	12	16	15	21
Other Income	11	16	8	35	12	15	5	4	-24	5	13	5	3	6	2	7	12	-68	5	8
Interest	2	1	3	5	2	1	4	2	2	2	1	1	5	1	2	2	2	1	1	1
Depreciation	9	8	8	8	8	8	7	7	7	7	6	6	5	5	5	5	4	4	4	4
Profit before tax	45	41	41	63	23	36	36	30	-4	40	59	22	-1	47	20	39	26	-39	30	37
Tax %	18	39	30	30	29	29	28	26	24	27	27	34	-561	37	21	30	11	25	26	29
Net Profit	37	25	29	44	17	26	26	22	-5	29	43	14	3	30	16	27	23	-49	22	26
Net Profit Growth % (QoQ)	48%	-13.8%	-34.1%	158.8%	-34.6%	-	18.2%	540%	-117.2%	-32.6%	207.1%	366.7%	-90%	87.5%	-40.7%	17.4%	146.9%	-322.7%	-15.4%	-
Net Profit Growth % (YoY)	117.6%	-3.8%	11.5%	100%	440%	-10.3%	-39.5%	57.1%	-266.7%	-3.3%	168.8%	-48.1%	-87%	161.2%	-27.3%	3.8%	-	-	-	-
TTM Net Profit	135	115	116	113	91	69	72	89	81	89	90	63	76	96	17	23	22	-1	48	0
EPS in Rs	3.36	2.2	2.58	4.08	1.47	2.26	2.31	1.97	-0.87	2.64	4.05	1.41	0.32	2.68	1.33	2.48	1.89	-4.83	2.05	2.35

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	927	810	770	752	747	577	689	899	815	798	547	407	345	397
Sales Growth %	-	5.1%	2.5%	0.6%	29.5%	-16.3%	-23.3%	10.3%	2%	46%	34.3%	18.1%	-13.1%	48.7%
Expenses	763	683	620	634	629	471	566	739	618	596	391	304	273	285
Operating Profit	164	127	151	117	118	107	123	160	197	203	156	103	71	111
OPM %	18	16	20	16	16	18	18	18	24	25	29	25	21	28
Other Income	71	36	0	18	-42	20	26	35	-8	12	24	20	28	14
Interest	12	8	7	10	5	6	8	4	23	20	19	16	18	10
Depreciation	33	29	26	19	17	17	13	9	21	20	13	11	11	6
Profit before tax	190	126	117	106	54	104	129	182	145	175	148	96	71	109
Tax %	29	28	30	28	57	29	26	30	39	36	32	36	42	46
Net Profit	135	90	82	77	23	74	95	127	89	113	100	61	41	60
Net Profit Growth %	50%	9.8%	6.5%	234.8%	-68.9%	-22.1%	-25.2%	42.7%	-21.2%	13%	63.9%	48.8%	-31.7%	-
EPS in Rs	12.21	8	7.21	6.8	1.45	6.64	9.43	11.99	5.7	7.95	8	5.81	3.97	5.6
Dividend Payout %	8	6	7	7	34	8	5	8	18	8	6	12	13	12

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	106	103	34	135	64	47	40	18	289	113	38	41	6
Cash from Investing Activity	-75	-83	-6	-103	-45	-40	-79	48	-249	-50	-29	-11	-124
Cash from Financing Activity	-30	-21	-25	-24	-21	-6	17	-76	-10	-40	-42	-8	110
Net Cash Flow	0	-1	3	9	-2	0	-22	-10	30	23	-34	22	-8

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	11	11	11	10	10	10	10	10	10	10	10	10	10	10	10
Reserves	1122	1040	999	957	873	808	798	725	636	526	476	402	327	277	248
Borrowings	52	88	94	100	102	109	122	126	102	118	225	132	160	173	148
Other Liabilities	215	162	178	145	171	181	147	168	157	206	311	218	166	123	165
Total Liabilities	1400	1301	1283	1212	1157	1109	1077	1030	905	860	1023	762	662	583	571
Fixed Assets	392	406	364	370	379	281	234	242	146	143	305	225	234	213	168
CWIP	39	21	24	8	3	22	2	0	47	0	4	9	0	4	1
Investments	10	4	4	4	8	2	0	0	0	0	0	0	0	0	0
Other Assets	959	870	890	830	768	803	840	788	712	717	714	527	428	365	402
Total Assets	1400	1301	1283	1212	1157	1109	1077	1030	905	860	1023	762	662	583	571

Delivery

#	Date	273 103% 553	Value (Cr)	Q/T 93	Del 38	Del 92
1	2-Jul	527	21	38	54	11
2	1-Jul	524	43	38	47	20
3	30-Jun	540	72	57	37	27
4	29-Jun	530	147	61	26	38
5	25-Jun	492	83	56	34	28
6	24-Jun	460	42	61	58	24
7	23-Jun	470	47	53	48	22
8	22-Jun	473	23	53	54	12
9	19-Jun	486	48	75	44	21
10	18-Jun	483	43	63	42	18
11	17-Jun	475	92	69	43	40
12	16-Jun	452	54	88	55	29
13	15-Jun	440	30	56	49	15
14	12-Jun	438	23	69	41	9
15	11-Jun	437	49	71	45	22
16	10-Jun	425	67	72	49	32
17	9-Jun	422	26	67	42	11
18	8-Jun	420	46	68	39	18
19	5-Jun	438	55	81	47	26
20	4-Jun	456	74	92	36	27
21	3-Jun	440	116	80	30	35
22	2-Jun	434	166	105	31	51
23	1-Jun	402	124	94	39	48
24	29-May	425	327	99	22	73
25	27-May	397	360	91	17	62
26	26-May	381	596	148	29	174
27	25-May	318	311	120	34	106
28	22-May	300	69	114	51	35
29	21-May	295	79	119	53	42
30	20-May	290	33	90	40	13
31	19-May	283	50	95	37	18
32	18-May	287	67	106	52	35
33	15-May	278	86	107	47	40
34	14-May	289	124	128	44	55

Daily Market Cap

Date	Total Market Cap	Change	Chg %
02-Jul	5,608c	95c	1.66
30-Jun	5,703c	59c	1.04
29-Jun	5,644c	445c	8.57
26-Jun	5,199c	121c	2.37
25-Jun	5,078c	210c	4.30
24-Jun	4,868c	99c	1.99
23-Jun	4,967c	16c	0.33
22-Jun	4,951c	190c	3.70
19-Jun	5,141c	96c	1.90
17-Jun	5,046c	234c	4.86
16-Jun	4,812c	157c	3.38
15-Jun	4,655c	32c	0.69
12-Jun	4,623c	12c	0.26
11-Jun	4,611c	111c	2.46
10-Jun	4,500c	0	0

Stock Checklist

Price is above from 52 week high low average: 89%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Jul26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.13%	-	0

Bliss GVS Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements